SYRS logo

Syros Pharmaceuticals (SYRS) CAPEX

SYRS Annual CAPEX

$272.00 K
-$969.00 K-78.08%

31 December 2023

1-Year Change

-78.08%
SYRS annual capital expenditures is down -78.08% year-on-year

3-Year Change

-91.85%
SYRS annual capital expenditures is down -91.85% over the past 3 years

All-time High

$12.64 M
SYRS annual capital expenditures is currently -97.85% below its historical high of $12.64 million

Sector Rank

20.67%
SYRS annual capital expenditures is higher than 20.67% of companies in Healthcare sector
Annual FCF-$109.98 M
SYRS annual free cash flow is -$109.98 million
Annual CFO-$109.71 M
SYRS annual cash flow from operations is -$109.71 million
Annual CFI$37.34 M
SYRS annual cash flow from investing activities is $37.34 million
Annual CFF$43.46 M
SYRS annual cash flow from financing activities is $43.46 million

SYRS CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SYRS Quarterly CAPEX

N/A

30 September 2024

All-time High

$8.16 M
SYRS quarterly capital expenditures is currently at an all-time high
Quarterly FCF-$20.69 M
SYRS quarterly free cash flow is -$20.69 million
Quarterly CFO-$20.69 M
SYRS quarterly cash flow from operations is -$20.69 million
Quarterly CFI$0.00
SYRS quarterly cash flow from investing activities is $0.00
Quarterly CFF$0.00
SYRS quarterly cash flow from financing activities is $0.00

SYRS Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SYRS TTM CAPEX

N/A

30 September 2024

All-time High

$13.84 M
SYRS TTM capital expenditures is currently at an all-time high
TTM FCF-$100.05 M
SYRS TTM free cash flow is -$100.05 million
TTM CFO-$100.02 M
SYRS TTM cash flow from operations is -$100.02 million
TTM CFI$1.95 M
SYRS TTM cash flow from investing activities is $1.95 million
TTM CFF$43.16 M
SYRS TTM cash flow from financing activities is $43.16 million

SYRS TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SYRS CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-78.1%--
3 y3 years-91.8%--
5 y5 years-80.3%--

SYRS CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-78.2%at low
5 y5-year-97.8%at low
alltimeall time-97.8%at low

Syros Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$272.00 K(-78.1%)
$38.00 K(>+9900.0%)
$272.00 K(-70.0%)
Sept 2023
-
$0.00(-100.0%)
$908.00 K(-26.5%)
June 2023
-
-$1000.00(-100.4%)
$1.24 M(-8.3%)
Mar 2023
-
$235.00 K(-65.1%)
$1.35 M(+8.6%)
Dec 2022
$1.24 M(-0.3%)
$674.00 K(+105.5%)
$1.24 M(+52.8%)
Sept 2022
-
$328.00 K(+195.5%)
$812.00 K(+2.3%)
June 2022
-
$111.00 K(-13.3%)
$794.00 K(-28.5%)
Mar 2022
-
$128.00 K(-47.8%)
$1.11 M(-10.8%)
Dec 2021
$1.25 M(-62.7%)
$245.00 K(-21.0%)
$1.25 M(+21.0%)
Sept 2021
-
$310.00 K(-27.6%)
$1.03 M(-17.1%)
June 2021
-
$428.00 K(+63.4%)
$1.24 M(-31.1%)
Mar 2021
-
$262.00 K(+803.4%)
$1.80 M(-46.0%)
Dec 2020
$3.34 M(-73.6%)
$29.00 K(-94.4%)
$3.34 M(-70.9%)
Sept 2020
-
$522.00 K(-47.2%)
$11.46 M(-15.2%)
June 2020
-
$988.00 K(-45.0%)
$13.51 M(-2.4%)
Mar 2020
-
$1.80 M(-78.0%)
$13.84 M(+9.5%)
Dec 2019
$12.64 M
$8.16 M(+217.4%)
$12.64 M(+170.3%)
DateAnnualQuarterlyTTM
Sept 2019
-
$2.57 M(+94.7%)
$4.68 M(+49.5%)
June 2019
-
$1.32 M(+123.4%)
$3.13 M(+71.5%)
Mar 2019
-
$591.00 K(+203.1%)
$1.82 M(+31.7%)
Dec 2018
$1.38 M(+68.6%)
$195.00 K(-80.9%)
$1.38 M(+10.2%)
Sept 2018
-
$1.02 M(+6281.3%)
$1.26 M(+347.0%)
June 2018
-
$16.00 K(-89.5%)
$281.00 K(-51.3%)
Mar 2018
-
$152.00 K(+126.9%)
$577.00 K(-29.7%)
Dec 2017
$821.00 K(-64.6%)
$67.00 K(+45.7%)
$821.00 K(-23.1%)
Sept 2017
-
$46.00 K(-85.3%)
$1.07 M(-11.2%)
June 2017
-
$312.00 K(-21.2%)
$1.20 M(+0.8%)
Mar 2017
-
$396.00 K(+26.1%)
$1.19 M(-48.6%)
Dec 2016
$2.32 M(+97.4%)
$314.00 K(+73.5%)
$2.32 M(+0.9%)
Sept 2016
-
$181.00 K(-40.1%)
$2.30 M(-18.8%)
June 2016
-
$302.00 K(-80.2%)
$2.83 M(+9.2%)
Mar 2016
-
$1.52 M(+420.5%)
$2.59 M(+142.8%)
Dec 2015
$1.18 M
$293.00 K(-58.8%)
$1.07 M(+37.8%)
Sept 2015
-
$712.00 K(+1030.2%)
$775.00 K(+1130.2%)
June 2015
-
$63.00 K
$63.00 K

FAQ

  • What is Syros Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Syros Pharmaceuticals?
  • What is Syros Pharmaceuticals annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Syros Pharmaceuticals?
  • What is the all time high TTM CAPEX for Syros Pharmaceuticals?

What is Syros Pharmaceuticals annual capital expenditures?

The current annual CAPEX of SYRS is $272.00 K

What is the all time high annual CAPEX for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high annual capital expenditures is $12.64 M

What is Syros Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, SYRS annual capital expenditures has changed by -$969.00 K (-78.08%)

What is the all time high quarterly CAPEX for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high quarterly capital expenditures is $8.16 M

What is the all time high TTM CAPEX for Syros Pharmaceuticals?

Syros Pharmaceuticals all-time high TTM capital expenditures is $13.84 M